Research ArticleClinical Studies
Open Access
The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease
TAKAYUKI MANABE, KUNINORI IWAYAMA, MASAYUKI CHUMA, YOSHIKAZU TASAKI and SEIJI MATSUMOTO
In Vivo May 2023, 37 (3) 1260-1265; DOI: https://doi.org/10.21873/invivo.13203
TAKAYUKI MANABE
1Clinical Research Support Center, Asahikawa Medical University Hospital, Asahikawa, Japan;
2Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan;
KUNINORI IWAYAMA
2Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan;
3Department of Pharmacotherapy and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Teine, Japan;
MASAYUKI CHUMA
2Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan;
YOSHIKAZU TASAKI
1Clinical Research Support Center, Asahikawa Medical University Hospital, Asahikawa, Japan;
2Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan;
SEIJI MATSUMOTO
1Clinical Research Support Center, Asahikawa Medical University Hospital, Asahikawa, Japan;
4Center for Advanced Research and Education, Asahikawa Medical University, Asahikawa, Japan
In this issue
In Vivo
Vol. 37, Issue 3
May-June 2023
The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease
TAKAYUKI MANABE, KUNINORI IWAYAMA, MASAYUKI CHUMA, YOSHIKAZU TASAKI, SEIJI MATSUMOTO
In Vivo May 2023, 37 (3) 1260-1265; DOI: 10.21873/invivo.13203
Jump to section
Related Articles
- No related articles found.